Your browser doesn't support javascript.
loading
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.
McClung, Michael R; Brown, Jacques P; Diez-Perez, Adolfo; Resch, Heinrich; Caminis, John; Meisner, Paul; Bolognese, Michael A; Goemaere, Stefan; Bone, Henry G; Zanchetta, Jose R; Maddox, Judy; Bray, Sarah; Grauer, Andreas.
  • McClung MR; Oregon Osteoporosis Center, Portland, OR, USA.
  • Brown JP; Australian Catholic University, Melbourne, Australia.
  • Diez-Perez A; Laval University and CHU de Québec Research Centre, Quebec City, QC, Canada.
  • Resch H; Medicine Hospital del Mar/IMIM, Autonomous University of Barcelona, Barcelona, Spain.
  • Caminis J; St Vincent Hospital, Vienna, Austria.
  • Meisner P; UCB Pharma, Brussels, Belgium.
  • Bolognese MA; UCB Pharma, Brussels, Belgium.
  • Goemaere S; Bethesda Health Research Center, Bethesda, MD, USA.
  • Bone HG; Ghent University Hospital, Gent, Belgium.
  • Zanchetta JR; Michigan Bone and Mineral Clinic, Detroit, MI, USA.
  • Maddox J; Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina.
  • Bray S; Amgen Inc., Thousand Oaks, CA, USA.
  • Grauer A; Amgen Ltd., Cambridge, UK.
J Bone Miner Res ; 33(8): 1397-1406, 2018 08.
Article en En | MEDLINE | ID: mdl-29694685

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Densidad Ósea / Posmenopausia / Denosumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Densidad Ósea / Posmenopausia / Denosumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article